ASCO进展胰腺癌医学演示课件.pptx

A Randomized Phase II trial of Adjuvant Chemotherapy with S-1 vs S-1 and Gemcitabine(GS) vs Gemcitabine alone(GEM) in Patients with resected Pancreatic Cancer (CAP-002 study);研究设计;Hideyuki Yoshitomi ,et al. 2013 ASCO abstract: 4056;毒性反应;JASPAC 01: Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer;研究设计;患者特征;肿瘤特征;OS;RFS;AEs;存活者EQ-5D效用指数;结论;对于JASPAC 01的临床结果我们该如何解读：;Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plusgemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma